Anadys Forms Collaboration With Gilead To Discover Novel Antiviral Compounds
Anadys’ uHTS-ATLAS™ to be used to screen important and challenging viral target
12-Jun-2002 -
San Diego, CA, June 10, 2002 - Anadys Pharmaceuticals, Inc. ("Anadys") and Gilead Sciences, Inc. (Nasdaq: GILD) announced today that they have entered into a collaboration to discover novel antiviral compounds. As part of the collaboration agreement, Anadys will design, configure and run ...
GILEAD Sciences
milestone payments
proteins
+2